Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol for acute kidney injury in severe malaria
ISRCTN84974248Phase 2Completed
- Sponsor
- European & Developing Countries Clinical Trials Partnership
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetaminophen in Malaria and acute kidney failure (AKF) (2 arms), sponsored by European & Developing Countries Clinical Trials Partnership. Primary endpoint: Correction of acute kidney injury at 48 hours. Started May 2021; status: completed.
02
Drugs
acetaminophen
03
Conditions
Malariaacute kidney failure (AKF)
Beyond the preview
Go deeper on ISRCTN84974248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84974248.